Journal of Internal Medicine Concepts & Practice >
Glucose in the target range of time is associated with chronic complications of diabetes
HUANG Yuanhao, SHEN Yuanyuan, HAN Tao, ZHANG Bingqing, FENG Wenhuan . Glucose in the target range of time is associated with chronic complications of diabetes[J]. Journal of Internal Medicine Concepts & Practice, 2023 , 18(05) : 359 -362 . DOI: 10.16138/j.1673-6087.2023.05.011
| [1] | Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369: m997. |
| [2] | Gabbay MAL, Rodacki M, Calliari LE, et al. Time in range: a new parameter to evaluate blood glucose control in patients with diabetes[J]. Diabetol Metab Syndr, 2020, 12: 22. |
| [3] | 中华医学会糖尿病学分会. 中国血糖监测临床应用指南(2021年版)[J]. 中华糖尿病杂志, 2021, 13(10): 936-948. |
| [4] | Runge AS, Kennedy L, Brown AS, et al. Does time-in-range matter? Perspectives from people with diabetes on the success of current therapies and the drivers of improved outcomes[J]. Clin Diabetes, 2018, 36(2): 112-119. |
| [5] | 王诗佳. 基于子午流注理论探讨甲状腺功能亢进症患者动态血糖谱波动特点[D]. 辽宁中医药大学, 2022. |
| [6] | Bergenstal RM, Ahmann AJ, Bailey T, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile(AGP)[J]. Diabetes Technol Ther, 2013, 15(3):198-211. |
| [7] | Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring[J]. Diabetes Care, 2017, 40(12): 1631-1640. |
| [8] | Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range[J]. Diabetes Care, 2019, 42(8): 1593-1603. |
| [9] | 冯中原, 石勇铨. 评估血糖控制的新指标: 葡萄糖在目标范围内时间[J]. 现代实用医学, 2020, 32(9): 1023-1025. |
| [10] | 隽娟, 杨慧霞. 美国糖尿病学会2023年“妊娠合并糖尿病诊治指南”解读[J]. 中华围产医学杂志, 2023, 26(4): 265-269. |
| [11] | Lu J, Ma X, Zhou J, et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes[J]. Diabetes Care, 2018, 41(11): 2370-2376. |
| [12] | Beck RW, Bergenstal RM, Riddlesworth TD, et al. Validation of time in range as an outcome measure for diabetes clinical trials[J]. Diabetes Care, 2019, 42(3): 400-405. |
| [13] | 邝嘉敏, 顾炽昌, 梁勇前. 血糖控制目标范围内时间与糖尿病视网膜病变的相关性分析[J]. 广州医科大学学报, 2021, 49(4): 99-102. |
| [14] | 余萍萍. TIR与2型糖尿病患者尿白蛋白水平的相关性研究[D]. 河北医科大学, 2020. |
| [15] | Mayeda L, Katz R, Ahmad I, et al. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease[J]. BMJ Open Diabetes Res Care, 2020, 8(1): e000991. |
| [16] | 马雅琼. TIR与2型糖尿病周围神经病变的相关性研究[D]. 河北医科大学, 2020. |
| [17] | Guo Q, Zang P, Xu S, et al. Time in range, as a novel metric of glycemic control, is reversely associated with presence of diabetic cardiovascular autonomic neuropathy independent of HbA1c in Chinese type 2 diabetes[J]. J Diabetes Res, 2020, 2020: 5817074. |
| [18] | 王迪文, 胡飞, 周路路, 等. 2型糖尿病患者并发大血管病变的影响因素分析[J]. 淮海医药, 2022, 40(4): 354-356. |
| [19] | 王丹钰, 刘凯坤, 张云, 等. 2型糖尿病患者葡萄糖目标范围内时间与冠状动脉病变严重程度的相关性研究[J]. 中华内分泌代谢杂志, 2021, 37(11): 973-978. |
| [20] | 陈中国, 朱晓丽, 万宇婷, 等. 颈动脉内膜中层厚度与冠心病的相关性分析[J]. 中华介入放射学电子杂志, 2019, 7(1):31-34. |
| [21] | Lu J, Ma X, Shen Y, et al. Time in range is associated with carotid intima-media thickness in type 2 diabetes[J]. Diabetes Technol Ther, 2020, 22(2): 72-78. |
| [22] | 任彩琴. 2型糖尿病患者葡萄糖目标范围内时间与颈动脉内膜中层厚度的相关性分析[D]. 兰州大学, 2021. |
| [23] | Wang Y, Lu J, Shen Y, et al. Association of time in range with lower extremity atherosclerotic disease in type 2 diabetes mellitus: a prospective cohort study[J]. Endocrine, 2022, 76(3): 593-600. |
| [24] | 言雪佳, 孙红, 杜宣, 等. 2型糖尿病患者持续葡萄糖监测指标与颈动脉粥样硬化的关系[J]. 山东医药, 2020, 60(32):47-50. |
| [25] | American Diabetes Association. 7 diabetes technology: standards of medical care in diabetes-2021[J]. Diabetes Care, 2021, 44 Suppl 1: S85-S99. |
| [26] | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4): 311-398. |
| [27] | Ang E, Lee ZX, Moore S, et al. Flash glucose monitoring (FGM): a clinical review on glycaemic outcomes and impact on quality of life[J]. J Diabetes Complications, 2020, 34(6):107559. |
| [28] | Vigersky RA, McMahon C. The relationship of hemoglobin A1c to time-in-range in patients with diabetes[J]. Diabetes Technol Ther, 2019, 21(2): 81-85. |
| [29] | Advani A. Positioning time in range in diabetes management[J]. Diabetologia, 2020, 63(2): 242-252. |
/
| 〈 |
|
〉 |
